Results 171 to 180 of about 169,813 (342)

P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY.

HemaSphere, 2022
C. Li, H. Geng, X. Zong, J. Zhou, Y. Zhang, J. Li, S. Jia, D. Wu   +7 more
doaj   +1 more source

Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases. [PDF]

Blood Res, 2022
Ahn H, Lee R, Cho SY, Lee DG.
europepmc   +1 more source

Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration

Advanced Science, EarlyView.
A dynamic fibrous hydrogel (DFH) is developed by covalent crosslinking of gelatin with tea‐derived trichomes, which integrates the structural and compositional fidelity of native extracellular matrix with photothermal and oxidative responsiveness, introducing a novel “stem cell recruits stem cell” strategy that orchestrates co‐homing of endogenous and ...
Jianmei Chen, Meiling Su, Xinyu Wu, Hongyu Wu, Haotian Wu, Pinghu Zhang, Xueying An, Zongguang Liu   +7 more
wiley   +1 more source

P394: FRONTLINE COMBINATION OF OLVEREMBATINIB AND PDT-ALL-2016 PEDIATRIC INSPIRED PROTOCOL IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2023
Kaibo Zhu, Ting Zhang, Zhixiang Wang, Qifa Liu, Hongsheng Zhou   +4 more
doaj   +1 more source

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era. [PDF]

Front Oncol
Okamoto A, Yoshida M, Kasahara S, Ara T, Ozeki K, Morishita T, Ikeda D, Kanaya M, Kajiguchi T, Suzuki Y, Kurahashi S, Horio T, Marumo Y, Oyake T, Saito S, Sawa H, Kimura SI, Nishiyama T, Kondo E, Hiraga J, Hosoi H, Masaki Y, Atsuta Y, Yamamoto H, Miyama T, Goto N, Iriyama C, Mihara K, Inamoto Y, Tomita A.   +29 more
europepmc   +1 more source

Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance. [PDF]

Infect Chemother, 2022
Choi H, Ahn H, Lee R, Cho SY, Lee DG.
europepmc   +1 more source

Optimization Of Alemtuzumab Dose For Graft-Versus-Host Disease Prophylaxis For Reduced Intensity Transplantation From Unrelated Donors For Patients With Hematologic Malignancies

, 2009
Vikas Gupta, Wei Xu, Robert Sutherland, Suzanne Kamel‐Reid, John Kuruvilla, David Loach, Jeffrey H. Lipton, Hans A. Messner   +7 more
openalex   +1 more source

B‐EPIC: A Transformer‐Based Language Model for Decoding B Cell Immunodominance Patterns

Advanced Science, EarlyView.
B‐Epic: Achieving high‐accuracy B cell epitope prediction through Transformer architecture. Comprehensive validation demonstrates B‐Epic's robust performance across diverse datasets. B‐Epic facilitates vaccine development for H. pylori and EBV, addressing critical public health challenges.
Jun‐Ze Liang, Youtao Wang, Cong Sun, Tao Liu, Zengfeng Wu, Lipeng Chen, Lina Chen, Penglin Li, Zhengkang Li, Cangui Zhang, Bingyun Lu, Ye Chen, Bing Gu, Qian Zhong, Xin Wei Wang, Mu‐Sheng Zeng, Jinping Liu   +16 more
wiley   +1 more source

A case report on Von Willebrand disease: A hematological challenge in pregnancy

Yajnaseni Banerjee, Tanmoy Mukherjee
openalex   +1 more source

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease

, 2015
Ciprian Tomuleasa, Bobe Petrushev, Madalina Vedean, Alexandru Irimie, Florin Zaharie, Ana Maria Rosu, Delia Dima, Andrei Cucuianu, Ioana Frinc   +8 more
openalex   +2 more sources